_PRIVATE_LIMITED.webp)
Arco Life Sciences (India) Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 23-12-2024
- Paid Up Capital ₹ 4.27 M
as on 23-12-2024
- Company Age 21 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.50 Cr
as on 23-12-2024
- Revenue 56.97%
(FY 2022)
- Profit 96.59%
(FY 2022)
- Ebitda 65.46%
(FY 2022)
- Net Worth 36.34%
(FY 2022)
- Total Assets 40.65%
(FY 2022)
About Arco Life Sciences (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.27 M.
The company currently has active open charges totaling ₹5.50 Cr.
Narendra Agrawal and Manju Agrawal serve as directors at the Company.
- CIN/LLPIN
U24230MH2003PTC142101
- Company No.
142101
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Sep 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationNagpur, Maharashtra
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Arco Life Sciences (India) Private Limited offer?
Arco Life Sciences (India) Private Limited offers a wide range of products and services, including Common Disease Medicines, Injectable Products, Hand Sanitizer & Disinfectant, Alcohol Based Hand Sanitizer.
Who are the key members and board of directors at Arco Life Sciences (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narendra Agrawal  | Managing Director | 27-Apr-2005 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manju Agrawal | Director | 24-Jun-2007 | Current |
Financial Performance of Arco Life Sciences (India).
Arco Life Sciences (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 56.97% increase. The company also saw a substantial improvement in profitability, with a 96.59% increase in profit. The company's net worth Soared by an impressive increase of 36.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arco Life Sciences (India)?
In 2022, Arco Life Sciences (India) had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Avisa Lifesciences Private LimitedActive 3 years 1 monthNarendra Agrawal and Manju Agrawal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 May 2006 | ₹5.50 Cr | Open |
How Many Employees Work at Arco Life Sciences (India)?
Arco Life Sciences (India) has a workforce of 47 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arco Life Sciences (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arco Life Sciences (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
